Service de Radiologie, Hôpital Maison Blanche, Université de Reims, Reims, France.
AJNR Am J Neuroradiol. 2013 Feb;34(2):360-5. doi: 10.3174/ajnr.A3200. Epub 2012 Jul 19.
The best approach between general anesthesia and conscious sedation to perform mechanical thrombectomy remains unknown. The goal of our study was to evaluate the feasibility, safety, and efficacy of mechanical thrombectomy under conscious sedation in patients with acute ischemic stroke, using the Solitaire FR device, in a prospective, single-center, single-arm study.
The study included consecutive patients with acute ischemic stroke due to a large artery occlusion within 6 hours of symptom onset for the anterior circulation, and within 24 hours for the posterior circulation. After intravenous thrombolysis (when no contraindications), thrombectomy was performed with the Solitaire device in patients under conscious sedation. Primary efficacy and safety end points were good functional outcome (mRS ≤2) at 3 months and mortality at 3 months. Secondary end points were recanalization (TICI ≥2) and failure rate.
From May 2010 to July 2011, 36 patients were treated. Median baseline NIHSS score was 17.5. The occlusion site was MCA in 21 patients (58.4%), ICA-MCA tandem occlusion in 9 patients (25.0%), terminal ICA in 2 patients (5.5%), and basilar artery in 4 patients (11.1%). Twenty-three patients (63.9%) received intravenous thrombolysis. Superselective catheterization of the occluded vessel was not feasible in 5/36 cases (13.9%). Successful revascularization was achieved in 28/36 patients (77.8%). After 3 months, 22 patients (61.1%) showed good functional outcome (mRS ≤2) and the median NIHSS score was 8.5. Overall mortality rate at 3 months was 22.2% (8/36).
In acute ischemic stroke, mechanical thrombectomy while under conscious sedation is feasible in a large percentage of cases (86.1%) and is associated with a short procedure delay and a high percentage of good functional outcomes at 3 months (61.1%).
在实施机械取栓术时,全麻与清醒镇静之间的最佳方法仍不清楚。我们的研究目的是使用 Solitaire FR 装置,在一项前瞻性、单中心、单臂研究中,评估急性缺血性卒中患者在清醒镇静下接受机械取栓术的可行性、安全性和疗效。
该研究纳入了发病 6 小时内前循环和 24 小时内后循环因大动脉闭塞导致的急性缺血性卒中且无静脉溶栓禁忌证的连续患者。静脉溶栓后,对清醒镇静下的患者使用 Solitaire 装置进行取栓术。主要有效性和安全性终点为 3 个月时的良好功能结局(mRS≤2)和 3 个月时的死亡率。次要终点为再通率(TICI≥2)和失败率。
2010 年 5 月至 2011 年 7 月,共治疗 36 例患者。基线 NIHSS 评分中位数为 17.5。21 例(58.4%)患者的闭塞部位为 MCA,9 例(25.0%)为 ICA-MCA 串联闭塞,2 例(5.5%)为终末颈内动脉闭塞,4 例(11.1%)为基底动脉闭塞。23 例(63.9%)患者接受了静脉溶栓治疗。36 例中有 5 例(13.9%)无法进行超选择性导管闭塞。28 例(77.8%)患者成功实现了再通。3 个月后,22 例(61.1%)患者表现出良好的功能结局(mRS≤2),NIHSS 评分中位数为 8.5。3 个月总死亡率为 22.2%(8/36)。
在急性缺血性卒中患者中,清醒镇静下机械取栓术在很大比例的病例中是可行的(86.1%),并且与较短的手术延迟和较高的 3 个月良好功能结局率(61.1%)相关。